HOME >> BIOLOGY >> NEWS
52 minority scientists receive APS/NIDDK travel fellowships totaling $90,000

BETHESDA, MD (March 27, 2006) One of the nation's leading non-profit science organizations is providing fellowships to underrepresented minority students -- part of an effort to retain qualified minority students in physiology and the biomedical sciences.

The American Physiological Society (APS), with the support of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health, will award a total of $90,000 to 52 fellows to attend APS scientific conferences, including Experimental Biology 2006 (EB) in San Francisco April 1-5.

The program is designed to encourage more minorities to become scientists and remain in the field. African-American, Hispanic, Native American and Pacific Islander undergraduate, graduate and post-doctoral students and faculty are eligible for the fellowships.

The APS has awarded travel fellowships to more than 500 minority students and faculty since 1987, when the program began.

In addition to paying transportation, registration and other costs, each fellow is paired with an established researcher, an APS member who is usually in the same research area as the student. More than 60 APS members volunteer each year to be mentors. A number of former minority travel fellows -- now established researchers with their own graduate students -- serve as mentors themselves.

The program provides many career networking opportunities. The mentor introduces the fellow to other established scientists at conferences, and the fellows meet other minority students at an orientation and reception for current and past travel fellows. APS also invites fellows to career workshops, sessions on special skills development, and other special sessions during the conference.

Past fellows have praised the program, saying:

  • "I received advice from several scientists concerning my research and the ins and
    '"/>



27-Mar-2006


Page: 1 2 3

Related biology news :

1. NCRR launches national network to connect investigators based at minority institutions
2. 38 minority scientists receive travel fellowships to Experimental Biology 2007 in D.C.
3. Study verifies more hazardous waste facilities located in minority areas
4. Conference supports minority students to pursue biomedical careers
5. The American Physiological Society names first-ever minority outreach fellow
6. Drs. Hrabowski, Summers share success strategies for producing minority scientists, engineers
7. AACR expands cancer research knowledge with scholarships for minority and women scientists
8. Nine minority physiology grad students each get $18,000 Porter Fellowship from APS
9. Science, AAAS select two for new minority internship
10. APS awards $63,000 in travel fellowships to minority scientists
11. AACR supports faculty at minority-serving institutions

Post Your Comments:
(Date:3/23/2015)... 2015   HOYOS Labs , a leading global ... that the Company will demonstrate multiple biometrics-based technologies under ... at Connect:ID on March 23 through 25, 2015, in ... highlight the IEEE Biometric Open Protocol Standard; free biometrics-based ... access control system. BOPS was invented by HOYOS Labs ...
(Date:3/23/2015)... Mar. 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market, announces its biometric payment technology, ... on CNBC television starting March 30 th . ... in New York markets. ... are excited about our new ad campaign following the recent ...
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
(Date:4/16/2015)... 2015 OncoTAb, Inc., ... Charlotte) spin-out company, announced today the appointment of ... as Chief Operating Officer (COO). Cooper brings to ... developing clinical diagnostic and biotechnology platforms in the ... Cooper’s extensive career transcends the field of medical ...
(Date:4/16/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... with G-treeBNT (ReGenTree LLC) has retained Ora, Inc. ... the orphan disorder, neurotrophic keratopathy (NK), and a ... (DES) in the U.S.  Both trials will be ... Each of these eye disorders was being targeted ...
(Date:4/16/2015)... 16, 2015  AnaptysBio, Inc., a leader in ... today announced the advancement of its first-in-class ... studies. The Company,s anti-IL-36R therapeutic antibody, called ... pustular psoriasis (GPP), an orphan systemic inflammatory ... wholly owned within AnaptysBio,s proprietary antibody pipeline ...
(Date:4/16/2015)... Switzerland , April 16, 2015 /PRNewswire/ ... Debiopharm Group ™ , a Swiss-based global biopharmaceutical ... medical needs as well as companion diagnostics, ... investigational compounds Debio 1143 (SMAC mimetic) and Debio 1347/CH5183284 ... the 2015 Annual meeting of the American Association for Cancer Research ...
Breaking Biology Technology:OncoTAb Names Dr. David L. Cooper as COO 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5AnaptysBio Advances First-In-Class Anti-IL-36 Receptor Antibody Program To Treat Orphan Inflammatory Disease 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 2Debiopharm International SA Announces Results of 2 Key Oncology Programs at 2015 AACR Conference 3
Cached News: